What are the steps for emergency asthma treatment protocol?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Emergency Asthma Treatment Protocol

Immediate Treatment (First Hour)

Administer oxygen, high-dose inhaled beta-agonists, and systemic corticosteroids immediately—these three interventions form the cornerstone of emergency asthma management and should be initiated without delay. 1

Step 1: Oxygen Administration

  • Administer supplemental oxygen via nasal cannula or face mask to maintain SpO₂ >90% (>95% in pregnant patients or those with heart disease) 1, 2
  • Continue oxygen monitoring until clear response to bronchodilator therapy occurs 1

Step 2: Inhaled Short-Acting Beta-Agonists (First-Line Bronchodilator)

  • Give albuterol 5 mg (or terbutaline 10 mg) via oxygen-driven nebulizer every 20 minutes for 3 doses in the first hour 1
  • Alternative: 4-12 puffs of albuterol via MDI with spacer every 20 minutes for 3 doses if patient can cooperate effectively 1, 2
  • After initial 3 doses, continue every 1-4 hours based on response 1, 2
  • For severe exacerbations (PEF <40% predicted), consider continuous nebulization rather than intermittent dosing 1

Step 3: Systemic Corticosteroids (Administer Immediately)

  • Give prednisolone 30-60 mg orally OR intravenous hydrocortisone 200 mg immediately 1
  • Oral administration is preferred—equally effective as IV but less invasive 1
  • Do not delay corticosteroid administration; clinical benefits may not appear for 6-12 hours 3, 4

Step 4: Add Ipratropium for Severe Exacerbations

For patients with severe exacerbations or those not responding adequately to initial beta-agonist therapy, add ipratropium bromide 0.5 mg to the nebulizer with albuterol 1, 5, 2

  • Repeat every 20 minutes for 3 doses, then every 6 hours until improvement 1, 2
  • This combination reduces hospitalization rates, particularly in severe airflow obstruction 2

Step 5: Reassess at 15-30 Minutes After Initial Treatment

Measure peak expiratory flow (PEF) or FEV₁, assess symptoms, vital signs, and oxygen saturation 1, 2

If Improving (PEF >50-75% predicted):

  • Continue oxygen and systemic corticosteroids 1
  • Continue nebulized beta-agonist every 4 hours 1
  • Consider discharge if PEF >75% predicted after observation 1

If NOT Improving (PEF remains <50% predicted or severe symptoms persist):

  • Give nebulized beta-agonist more frequently, up to every 15-30 minutes 1
  • Continue ipratropium if not already added 1
  • Consider IV magnesium sulfate 2g over 20 minutes for severe refractory cases 2, 6
  • Arrange for hospital admission 1

Step 6: Consider Additional Interventions for Life-Threatening Features

Life-threatening features include:

  • PEF <33% predicted, silent chest, cyanosis, feeble respiratory effort, bradycardia, hypotension, exhaustion, confusion, coma, or PaCO₂ ≥42 mmHg 1, 5, 2

For life-threatening exacerbations:

  • Give IV aminophylline 250 mg over 20 minutes OR subcutaneous terbutaline 250 µg over 10 minutes 1
  • Do NOT give bolus aminophylline to patients already taking oral theophyllines 1
  • Consider ICU transfer if deteriorating PEF, worsening hypoxia (PaO₂ <8 kPa), hypercapnia (PaCO₂ >6 kPa), exhaustion, confusion, or drowsiness 1

Step 7: Monitoring During Treatment

  • Measure and record PEF 15-30 minutes after starting treatment, then according to response 1
  • Continue high-dose steroids: prednisolone 30-60 mg daily OR IV hydrocortisone 200 mg every 6 hours 1
  • Obtain chest X-ray if suspected pneumothorax, pneumonia, or pneumomediastinum 1, 6

Common Pitfalls to Avoid

  • Do NOT administer sedatives of any kind—contraindicated in acute asthma 1, 2
  • Do NOT give antibiotics unless bacterial infection (pneumonia/sinusitis) is confirmed 1, 2
  • Do NOT delay corticosteroid administration—underuse is a common factor in preventable asthma deaths 1, 5
  • Do NOT rely solely on clinical assessment—use objective measurements (PEF/FEV₁) as severity is often underestimated 1, 5
  • Avoid chest physiotherapy and mucolytics—not helpful in acute management 1, 2

Criteria for Hospital Admission

Admit if any of the following persist after initial treatment: 1

  • Any life-threatening features present
  • PEF <33% predicted after initial treatment
  • Features of severe attack persist (inability to complete sentences, pulse >110, respirations >25, PEF <50% predicted)
  • Lower threshold for admission if: afternoon/evening presentation, recent nocturnal symptoms, previous severe attacks, poor social circumstances 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Asthma Exacerbation Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Acute severe asthma (status asthmaticus).

Allergy and asthma proceedings, 2019

Research

Chapter 14: Acute severe asthma (status asthmaticus).

Allergy and asthma proceedings, 2012

Guideline

Management of Severe Asthma in the Emergency Room

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Subcutaneous Emphysema Extending into the Epidural Space After Asthma Exacerbation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.